首页 | 本学科首页   官方微博 | 高级检索  
检索        

过氧化物酶体增殖物激活受体γ配体抑制大鼠肝纤维化的实验研究
引用本文:郭晏同,赵景明,宋磊,周迈,焦岗军,彭吉润,李涛,冷希圣.过氧化物酶体增殖物激活受体γ配体抑制大鼠肝纤维化的实验研究[J].中华普通外科杂志,2008,23(10).
作者姓名:郭晏同  赵景明  宋磊  周迈  焦岗军  彭吉润  李涛  冷希圣
作者单位:1. 北京积水潭医院普外科,北京大学第四临床医学院,100035
2. 民航总医院普外科
3. 北京大学人民医院普外科
摘    要:目的 研究过氧化物酶体增殖物激活受体γ(peroxisome proliferator activated receptorgamma,PPARγ)配体对大鼠肝纤维化的作用.方法 将Wistar大鼠40只随机分为两组,对照组(20只)和罗格列酮组(20只).所有动物使用饮水中加人质量比0.3‰硫代乙酰胺的方法 制作肝纤维化模型.对照组喂饲普通颗粒饲料.罗格列酮组喂饲含200 ppm罗格列酮的颗粒饲料.喂饲6个月后,用RT-PCR方法 检测肝纤维化大鼠肝脏PPARγ、TGF-β 1 及Ⅰ型前胶原mRNA表达,用Westernblot法检测PPARγ、TGF-β 1 、Ⅰ型胶原及α平滑肌肌动蛋白(α-SMA)表达,用Van Gieson(VG)染色的方法 检测肝组织切片的胶原表达情况.结果 罗格列酮组与对照组相比,PPARγmRNA表达显著增强(t=6.93,P<0.01),TGF-β 1 mRNA(t=3.89,P<0.01)和Ⅰ型前胶原mRNA表达显著降低(t=5.67,P<0.01).PPARγ、TGF-β 1 及Ⅰ型胶原蛋白表达所得结果 与RT-PCR结果 相一致.罗格列酮组与对照组相比,α-SMA表达显著降低(t=3.12,P<0.01).罗格列酮组肝组织切片的胶原染色低于对照组(t=3.47,P<0.01).结论 PPARγ配体能够抑制大鼠纤维化肝脏的胶原产生,在体内具有一定的抗肝纤维化作用.

关 键 词:肝硬化  胶原  过氧化物酶体增殖物激活受体

Peroxisome proliferator activated receptor gamma ligand suppresses hepatic fibrosis in rats
GUO Yan-tong,ZHAO Jing-ming,SONG Lei,ZHOU Mai,JIAO Gang-jun,PENG Ji-run,LI Tao,LENG Xi-sheng.Peroxisome proliferator activated receptor gamma ligand suppresses hepatic fibrosis in rats[J].Chinese Journal of General Surgery,2008,23(10).
Authors:GUO Yan-tong  ZHAO Jing-ming  SONG Lei  ZHOU Mai  JIAO Gang-jun  PENG Ji-run  LI Tao  LENG Xi-sheng
Abstract:Objective To study the effect of peroxisome proliferator-activated receptor garama (PPARγ) ligand on hepatic fibrosis in rats. Methods Forty Wistar rats were randomly divided into two groups: the control group(20 rats) ,in which liver cirrhosis was induced by adding 0. 3‰ thioacetamide in the fodder for 6 months, and rosiglitazone group(20 rats) in which 200 ppm of rosiglitazone in combination with 0. 3‰ thioacetamide was added in the fodder. Liver tissue's mRNA expression of PPARγ, TGF-β1 ,type Ⅰ pro-collagen and α-smooth muscle actin(α-SMA) was detected by RT-PCR. The protein expression of PPARγ, TGF-β1 ,type Ⅰ collagen and α-SMA was detected by Western blot. The expression of collagenof liver histological section was evaluated by Van Gieson (VG) staining. Results The expression ofPPARγ at mRNA level significantly increased in rosiglitazone group compared with those in the control group ( t = 6. 93, P < 0. 01 ), while the expression of TGF-β1 ( t = 3. 89, P < 0. 01 ) and type Ⅰ pro-collagen ( t =5.67,P <0. 01 ) were lower than that in the control group. The protein expression of PPARγ, TGF-β1 and type Ⅰ collagen was in similar tendence with that of mRNA expression. The expression of α-SMA decreased significantly in rosiglitazone group compared with that in the control group (t = 3. 12,P < 0.01 ). The collagen stainings of liver histological section in rosiglitazone group was lower than those in the control group (t = 3.47, P < 0. 01 ). Conclusion PPARγ ligand inhibits the production of collagen in fibrofic livers in rats and prevents hepatic fibrosis in vivo.
Keywords:Liver cirrhosis  Collagen  Peroxisome proliferator activated receptors
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号